MKP10241 for diabetes mellitus, type 2

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 1 Aug 2025: Trial registered, NCT07098663
  2. 12 Aug 2025: Trial started, NCT07098663

The trials

NCT07098663: Food Effect, Efficacy and Safety of MKP10241 in Healthy and Obese Adult Participants, With and Without Diabetes

State
Under way
Phase
Phase 2
People
68 planned
Started
12 Aug 2025
Primary completion
19 Jan 2026
Arms
Part 1- MKP10241 400 mg, Part 2 - MKP10241 200 mg, 300 mg and 400 mg, Part 3 - MKP10241 300 mg and 400 mg
Results
None posted
  1. 1 Aug 2025: Trial registered
  2. 12 Aug 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.